Recent studies show that APOE exerts its neuroimmune modulatory function partly through interactions with the triggering receptor expressed on myeloid cells 2 (TREM2), following the discovery that mutations in TREM2 were associated with increased risk of AD [116,117]. The gene discussed is APOE; the disease is Alzheimer disease.